Next in the FPM Conversation Series: “Enabling a Greater Diversity of People in Clinical Trials”

The next in our FPM Conversation Series will take place on 18 March 2021. This online meeting will discuss and debate scientific and social issues surrounding enabling a greater diversity of people in clinical trial programs, and the implications for Pharmaceutical Medicine professionals who design study protocols/programs.

Bringing together an expert panel with extensive experience in pharmaceutical medicine clinical trial program strategy and design, this conversation aims to further explore areas such as genetic PK-PD heterogeneity, appropriate inclusion of ethnically diverse populations and less commonly studied patients & diseases.